Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: an urgent need for future paediatric practice
- PMID: 33653714
- DOI: 10.1136/archdischild-2021-321683
Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: an urgent need for future paediatric practice
Keywords: microbiology; molecular Biology.
Conflict of interest statement
Competing interests: RH has received consultancy fees and conference travel support from 4D Pharma and Nutricia. GLH has received consultancy fees and conference travel support from Ferring and Proctor & Gamble. GLH is also a member of Enterobiotix scientific advisory panel. KG has received research grants, speaker’s and consultancy fees from Nestle Health Science, Nutricia-Danone, Mylan, Abbott and Baxter. THI has received speaker’s fees from Vifor, Pharmacosmosos, Shield, Takeda, Roche and Ferring. JRM has received consultancy fees from Enterobiotix.
Comment on
-
'Next Generation Sequencing' as a diagnostic tool in paediatrics.Arch Dis Child. 2021 Jan;106(1):1-2. doi: 10.1136/archdischild-2020-320251. Epub 2020 Oct 29. Arch Dis Child. 2021. PMID: 33122330 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources